Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2000-6-29
pubmed:abstractText
Hepatitis B virus (HBV) replicates by reverse transcription of an RNA intermediate, the pregenomic RNA. The first step of HBV genome replication is the encapsidation of the pregenomic RNA encoding the encapsidation signal, termed epsilon, into the core particles, which is preceded by recognition and binding of HBV DNA polymerase to epsilon. The pregenomic RNA contains two identical epsilon elements due to its terminal redundancy: one near the 5' end and another near the 3' end. Despite the fact that both epsilon elements have an identical sequence, only the 5' epsilon, but not the 3' epsilon, is functional for encapsidation. To understand the molecular nature of this position effect, we made a series of lacZ RNA expression plasmids which contain the epsilon element at various positions from the 5' end of the transcripts. Following transfection, the lacZ RNAs in cytoplasmic core particles were measured by RNase protection assay for encapsidation. The results indicated that the lacZ RNAs with epsilon positioned up to 65 nucleotides from the 5' end were encapsidated, whereas the lacZ RNAs with epsilon positioned further downstream were not. Interestingly, the cap-free lacZ RNA transcribed by T7 RNA polymerase was not encapsidated, implying that the 5' cap structure is required for encapsidation of the pregenomic RNA. We hypothesized that HBV DNA polymerase must somehow recognize the cap structure and/or its associated factors, as well as the 5' epsilon, for encapsidation to occur.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-1380455, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-1384989, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-1548764, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-1690862, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-1733109, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2033673, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2209549, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2214019, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2261646, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2293662, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2440339, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-2463093, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-3039907, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-3095828, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-3806799, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-399327, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-6180831, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-6286115, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-7511168, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-7520092, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-7684464, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-7690471, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-7707534, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-8223577, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-8791732, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-8824700, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-8825147, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-8914001, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823855-9561852
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5502-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10823855-Base Sequence, pubmed-meshheading:10823855-Binding Sites, pubmed-meshheading:10823855-DNA-Directed DNA Polymerase, pubmed-meshheading:10823855-DNA-Directed RNA Polymerases, pubmed-meshheading:10823855-Genes, Reporter, pubmed-meshheading:10823855-Genetic Engineering, pubmed-meshheading:10823855-Genome, Viral, pubmed-meshheading:10823855-Hepatitis B virus, pubmed-meshheading:10823855-Humans, pubmed-meshheading:10823855-Models, Biological, pubmed-meshheading:10823855-Molecular Sequence Data, pubmed-meshheading:10823855-Mutation, pubmed-meshheading:10823855-Nucleic Acid Conformation, pubmed-meshheading:10823855-RNA, Viral, pubmed-meshheading:10823855-RNA Caps, pubmed-meshheading:10823855-Ribonucleases, pubmed-meshheading:10823855-Transfection, pubmed-meshheading:10823855-Tumor Cells, Cultured, pubmed-meshheading:10823855-Viral Proteins, pubmed-meshheading:10823855-Virus Assembly
pubmed:year
2000
pubmed:articleTitle
Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA.
pubmed:affiliation
Department of Biochemistry and Institute of Bioscience and Biotechnology, Yonsei University, Seoul, Korea 120-749.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't